Your browser doesn't support javascript.
loading
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma.
Martinez-Baquero, Diana; Sakhdari, Ali; Mo, Huan; Kim, Do Hwan; Kanagal-Shamanna, Rashmi; Li, Shaoying; Young, Ken H; O'Malley, Dennis P; Dogan, Ahmet; Jain, Preetesh; Wang, Michael L; McDonnell, Timothy J; Miranda, Roberto N; Vega, Francisco; Medeiros, L Jeffrey; Ok, Chi Young.
Afiliação
  • Martinez-Baquero D; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Sakhdari A; Department of Pathology, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Mo H; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Kim DH; Department of Laboratory Medicine and Pathobiology, University Health Network, The University of Toronto, Toronto, ON, Canada.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Li S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Young KH; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • O'Malley DP; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Dogan A; Division of Hematopathology and Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
  • Jain P; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Wang ML; NeoGenomics, Aliso Viejo, CA, USA.
  • McDonnell TJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Miranda RN; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Vega F; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Medeiros LJ; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Ok CY; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Mod Pathol ; 34(12): 2183-2191, 2021 12.
Article em En | MEDLINE | ID: mdl-34376807
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfoma de Célula do Manto / Proteína Potenciadora do Homólogo 2 de Zeste Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Linfoma de Célula do Manto / Proteína Potenciadora do Homólogo 2 de Zeste Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article